Premature luteinization is a possible cause of infertility in women. It is currently unknown whether environmental chemicals can induce changes associated with premature luteinization. Using rat granulosa cells (GC) in vitro, we demonstrated that exposure to atrazine (ATR), a widely used herbicide, causes GC phenotype that resembles that of human premature luteinization. At the end of the 48-h stimulation with FSH, ATR-exposed GC showed (1) higher levels of progesterone, (2) overexpression of luteal markers (Star and Cyp11a1), and (3) an increase in progesterone:estradiol ratio above 1. Mechanistic experiments were conducted to understand the signaling events engaged by ATR that lead to this phenotype. Western blot analysis revealed prolonged phosphorylation of protein kinase B (AKT) and cAMP response element-binding protein (CREB) in ATR-and FSH-exposed GC. An increased level of ERK1/2-dependent transcriptional factor CCATT/enhancerbinding protein beta (CEBPB) was observed after 4 h of ATR exposure. Inhibitors of PI3K (wortmannin) and MEK (U0126) prevented ATR-induced rise in progesterone level and expression of luteal markers in FSH-stimulated GC. Atrazine intensified AKT and CEBPB signaling and caused Star overexpression in forskolinstimulated GC but not in epidermal growth factor (EGF)-stimulated GC. In the presence of rolipram, a specific inhibitor of phosphodiesterase 4 (PDE4), ATR was not able to further elevate AKT phosphorylation, CEBPB protein level, and Star mRNA in FSHstimulated GC, suggesting that ATR inhibits PDE4. Overall, this study showed that ATR acts as a FSH sensitizer leading to enhanced cAMP, AKT, and CEBPB signaling and progesterone biosynthesis, which promotes premature luteinization phenotype in GC.
INTRODUCTION
Infertility adversely affects many couples worldwide [1] . Based on the predictive model about the world population, it has been estimated that 72.4 million women are currently infertile [2] . An ongoing and rapid increase in reproductive diseases and a decline in reproductive functions have been observed in recent years. Environmental chemicals have been implicated as one of the potential risk factors that may be contributing to the observed changes in reproductive health [3, 4] . Therefore, a greater understanding of the influence of endocrine-disrupting chemicals on cellular and molecular events in the ovary and their role in ovarian pathophysiology could provide important insights into the potential reproductive harm in humans.
Atrazine, (2-chloro-4-ethylamino-6-isopropylamino)-s-triazine (ATR), is the most heavily applied agricultural pesticide for crop production worldwide. Atrazine is banned in European Union countries, while the maximal contaminant level of 0.003 mg/L in drinking water is currently under review in the United States [5] . There is a growing concern that agricultural runoff of this chemical can affect nontarget animal species. The actual ATR levels in the environment can exceed maximal permissible concentrations, sometimes reaching more than 0.02 mg/L [6] . Humans can be exposed to ATR primarily from ingestion of contaminated drinking water and from dermal contact or ingestion following agricultural and lawn applications. Atrazine is toxicologically important, primarily because it acts as an endocrine disruptor and has a potential to interfere with steroidogenesis. Among the steroid-disrupting outcomes, the effect of ATR on aromatase (CYP19A1), an enzyme involved in estradiol synthesis, is the most intensively investigated. Increases in Cyp19a1 expression and activity have been observed in mammalian cells, resulting in misbalance in the conversion of testosterone to estrogens [7] [8] [9] [10] . This effect is also documented in other vertebrate classes such as fish, amphibians, reptiles, and birds [11] . We have recently revealed that ATR selectively decreases the luteinizing hormone receptor (Lhr) mRNA level during FSH stimulation of granulosa cells (GC). Furthermore, expression of ovulatory genes, including amphiregulin, epiregulin, and progesterone receptor (Pgr), was diminished in the human chorionic gonadotropin (hCG)-stimulated cells [12] . In addition to this effect, it has been shown that ATR induces luteal cell hypertrophy and increases progesterone production by newly formed corpora lutea in female rats [13] . Atrazine also affects male steroidogenesis by interfering with testosterone production in rat and murine Leydig cells [14] [15] [16] .
It is obvious that ATR has detrimental effects on steroidogenesis in reproductive cells; however, whether exposure to this pesticide might have possible consequences for GC function is not clear. During transition from the immature to the preovulatory follicular stage, FSH enhances estradiol biosynthesis together with expression of proliferating and differentiating genes, including Cyp19a1 and Lhr. Activation of adenylyl cyclase (AC) by FSH increases production of adenosine monophosphate (cAMP), which in turn stimulates cAMP-dependent protein kinase (PKA). Through PKA activation, FSH then phosphorylates the Ser133 residue of CREB [17] . Recently, it has been demonstrated that PKA promotes phosphorylation of the insulin receptor substrate-1, a binding site for the regulatory subunit of phosphoinositide 3-kinase (PI3K) that activates the catalytic subunit. Activation of PI3K leads to activation of AKT through phosphorylation of Thr308 and Ser473 [18] . In addition to the cAMP and AKT signaling, FSH promotes ERK1/2 phosphorylation. In immature GC, FSH activates RAS, thus leading to mitogen-activated protein kinase (MEK) activation, which further phosphorylates ERK1/2. Activation of RAS occurs either directly by SRC kinase or indirectly by releasing the epidermal growth factor (EGF)-like growth factors and activating the epidermal growth factor receptor (EGFR) [19] . In the FSH-stimulated GC, ERK1/2 is involved in up-regulation of steroidogenic acute regulatory protein (Star) and cholesterol side-chain cleavage enzyme (Cyp11a1) [19] . In preovulatory GC, this signaling finally reprograms GC to cease dividing and terminally differentiate into luteal cells. It increases progesterone but suppresses estradiol production [20] . Most of these ovarian actions of ERK1/2 are transmitted through the CEBPB transcriptional factor [21] .
It has been demonstrated that the above-mentioned cascades could be affected by ATR. In a previous study, we suggested that ERK1/2 signaling was affected by ATR, suppressing Cyp19a1 and Lhr mRNA expression and estradiol production, thus compromising the ability of GC to respond to hCG [12] . Others have identified cAMP, AKT, and ERK1/2 signaling as targets of ATR action in human placental choriocarcinoma (JGE-3) cells [10] . It has been shown that one of the mechanisms by which ATR affects signaling properties in heart cells was through competitive inhibition of phosphodiesterase (PDE) activity [22] . We have previously suggested that inhibition of the PDE4 activity was a critical event for an increase in cAMP production in rat pituitary and testicular Leydig cells after ATR exposure [23] .
Intracellular cAMP concentration is regulated either at the level of de novo cAMP production by AC or at the level of degradation by the cAMP-specific PDEs. The cAMP-specific PDE4s are expressed in granulosa and theca cells, but not in the oocytes [24] . PDE4D plays a critical role in cAMP signaling during differentiation of GC and is required for normal ovulation. PDE4D-deficient mice exhibit an altered pattern of cAMP accumulation induced by LH, impaired female fertility, and a markedly decreased ovulation rate. The lack of PDE4D primarily permits accumulation of cAMP, resulting in entrapment of oocytes in immature luteinized follicles [25] .
In this study, we examined the role of ATR and a possible mechanism in development of premature luteinization using the immature rat GC model. We used FSH to trigger in vitro proliferation and differentiation of GC and analyzed ATR toxicity during this important period of GC development. We showed that ATR causes dysfunction in the cAMP-, AKT-, and ERK1/2-signaling pathways most likely through inhibition of PDE4, which is the main regulator of cAMP in GC [26] [27] [28] . Changes in the properties of these signaling pathways represent the beginning of a complex modification of the GC function leading to a condition known in humans as premature luteinization. In our current study, the ATR-exposed GC displayed a higher level of progesterone during FSH stimulation. This was accompanied with an elevation of Star and Cyp11a1 expression above the normal level and an increase in progesterone:estradiol ratio above 1. Therefore, through simultaneous activation of the cAMP-, AKT-, and CEBPB-signaling pathways, ATR causes an inappropriate rise in progesterone production during FSH stimulation, thus leading to a premature luteinization phenotype of GC in vitro.
MATERIALS AND METHODS

Chemicals
Atrazine, Dulbecco-modified Eagle medium/nutrient mixture F-12 Ham, bovine serum albumin (BSA) fraction V, penicillin, streptomycin, ethylenediaminetetraacetic acid, U0126, wortmannin, rolipram, and 3-isobutyl-1-methylxanthine (IBMX) were obtained from Sigma-Aldrich Company. Purified recombinant hFSH was from Serono. Phospho-AKT and phospho-CREB antibodies were obtained from Cell Signaling Technology, whereas CEBPB was from Santa Cruz Biotechnology.
Cell Culture
Granulosa cells were obtained from the immature (21-24 days old) female Wistar rats that had been treated with estradiol (2 mg/day, injected subcutaneously in 200 ll of sesame oil) for 4 days. Animals were raised in the animal facility of the Department of Biology and Ecology (University of Novi Sad) under controlled environmental conditions (228C 6 28C and 14L:10D) with food and water ad libitum. Experiments were approved by the Ethics Committee for Protection and Welfare of Experimental Animals of the University of Novi Sad. Granulosa cells were isolated as previously described [29] . For each experiment, GC were obtained from six to nine estradiol-treated female rats. The cells were pooled together and plated in 24-well plates (0.35 3 10 6 cells/well) that had been precoated with bovine fibronectin. The cells were incubated at 378C in the culture medium consisting of Dulbecco-modified Eagle medium/nutrient mixture F-12 Ham 1:1 (v/v) containing 100 international units/ml penicillin, 0.1 mg/ml streptomycin, and 0.1% BSA. One day after plating, the cells were treated as described in the figure legends.
Hormone Measurements
Progesterone level in the incubation medium was estimated by an enzymelinked immunosorbent assay (ELISA) (obtained as a generous gift from Aleksandar Milovanovic, M.Sc., Scientific Veterinary Institute Novi Sad, Serbia). The assay is based on competition between the horseradish peroxidaseconjugated hormone and the standard or the samples for a limited number of the progesterone-specific antibody-binding sites. A formed complex binds to the goat anti-rabbit antibody (1:250; MP Biomedicals) that had been previously attached to the 96-well plate. Following a 4-h incubation period, the plate was washed and the reaction was initiated by addition of the substrate (3,3 0 ,5,5 0 -tetramethylbenzidine) and then terminated by the stop solution to yield the product detectable at 450 nm on a plate reader (Thermo Labsystems). A standard curve ranging from 0.02-10 ng/ml was generated for progesterone quantification. Samples from all the experiments were run in one assay. The intraassay variation coefficient of the progesterone assay was 4.8%. Estradiol level in the incubation medium was estimated by a radioimmunoassay according to the procedure described previously [30] . (The estradiol antiserum was a generous gift from Gordon D. Niswender, Colorado State University.) Intra-and interassay variation coefficients were 5.8% and 7.5%, respectively.
Quantitative RT-PCR Analysis
Total RNA from GC was extracted using the TRIzol reagent, followed by DNAse I treatment (Applied Biosystems). Total RNA was transcribed into cDNA, and quantitative RT-PCR (qRT-PCR) was performed using the SYBR Green PCR as previously described [15] . Gene-specific primer pairs are shown in Table 1 . The data obtained from the qRT-PCR reaction were analyzed using the comparative cycle threshold method [31] in SDS Relative Quantification Manager Software (Applied Biosystems) with an automated fluorescence threshold (DR n ) setting and then normalized to glyceraldehyde 3-phosphate dehydrogenase (Gapdh). Atrazine treatment had no effect on Gapdh expression.
Western Blot Analysis
One day after plating, GC were treated as described in the figure legends followed by cell lysis in the lysis buffer (150 mM NaCl, 50 mM Tris, and 1% Triton X-100, pH 7.4) containing protease and phosphatase inhibitors at 48C for 30 min. Afterward, the lysates were collected and centrifuged at 10 000 3 g for 5 min to remove debris. Protein concentration in the supernatants was determined using the Bio-Rad D c kit. A total of 5-15 lg of proteins were POGRMIC-MAJKIC ET AL. separated using the SDS-PAGE electrophoresis system and transferred to polyvinylidene fluoride membrane followed by blocking in the blocking buffer (150 mM NaCl and 50 mM Tris, pH 7.4, containing 3% BSA and 0.1% Tween-20) for 2 h at room temperature (RT). Primary antibodies for phospho-AKT (1:3000), phospho-CREB (1:2000), and CEBPB (1:1000) in the blocking buffer were added to the membranes for an overnight incubation at 48C. The membranes were then washed five times and the horseradish peroxidaseconjugated secondary antibody (diluted 1:3000 in 150 mM NaCl and 50 mM Tris, pH 7.4, containing 0.1% BSA) was subsequently used for 1 h incubation at RT. The membranes were washed four times prior to developing using the SuperSignal West Femto kit (Thermo Scientific). To analyze the loading accuracy, polyvinylidene fluoride membranes were stripped in the stripping buffer (65 mM Tris-HCl, 20% sodium dodecyl sulfate, and 0.7% bmercaptoethanol) and reprobed with GAPDH (1:3000) antibody. The Western blot signals were visualized with myECL imager (Thermo Scientific) and quantified using the ImageJ software [32] .
Sulforhodamine B Assay
Sulforhodamine B (SRB) assay was carried out to determine whether ATR treatment affected GC number. Briefly, GC were plated in a 96-well plate, treated for 72 h with ATR, and subsequently fixed for 1 h at 48C by adding 50 ll of 50% w/v trichloroacetic acid per well. After fixation, the cells were washed five times with distilled water and stained with 100 ll of 0.4% SRB in 1% acetic acid for 30 min at RT in the dark. The cells were washed five times with 1% acetic acid and air-dried. The stain was solubilized in 10 mM Tris, pH 10.5, and the light absorption was measured using the Thermo Labsystems Multiscan EX reader set at 492 nm, with a reference wavelength at 690 nm.
Statistical Analysis
Statistical comparisons were performed by one-way analysis of variance (ANOVA) with Tukey multiple comparison posttest or paired t-test, where appropriate, using the Prism 5 software package (GraphPad Software). A P value of , 0.05 was considered significant.
RESULTS
Atrazine Increases Progesterone and Up-Regulates Star and Cyp11a1 in FSH-Stimulated GC
To determine the effect of ATR on progesterone production, immature GC were exposed to ATR (20 lM) during 48 h of FSH stimulation. In our previous work, we conducted a doseresponse study and determined that only 20 lM ATR inhibited estradiol production and Cyp19a1 and Lhr mRNA expression in the FSH-stimulated GC with no obvious cytotoxic effect [12] . Based on this result, we further sought to determine whether 20 lM ATR exerted its effect on other GC functions such as progesterone biosynthesis and proliferation. Others have shown that 10 lM ATR, but not lower doses, affected progesterone production in porcine GC [33] . Here, we showed that 20 lM ATR had no effect on basal progesterone level in GC (Fig. 1A) . However, in the FSH-stimulated cells, ATR strongly enhanced progesterone production, causing approximately a 4-fold increase compared to the production in GC treated with FSH alone (Fig. 1A) . These data led us to analyze the mRNA expression of STAR and CYP11A1, two principal proteins involved in progesterone biosynthesis in GC. The results showed that FSH alone induced only a moderate expression of Star and Cyp11a1 mRNA after 48 h. However, addition of ATR strongly potentiated the FSH-driven expression of both transcripts (Fig. 1, B and C) . Under the same exposure conditions, mRNA levels for estrogen receptor beta (Esr2) (Fig. 1D) and Pgr (Fig. 1E) were not changed by ATR. These results suggest that ATR potentiates the luteinization process during the FSH-induced proliferation and differentiation of GC by promoting the activity of the progesterone biosynthetic pathway.
Atrazine Increases CREB and AKT Phosphorylation and CEBPB Level in FSH-Stimulated GC
In an attempt to clarify the mechanism of ATR action, we investigated the activity of three major signaling pathways involved in progesterone biosynthesis in GC, namely cAMP, AKT, and ERK1/2 [19] . We assessed the phosphorylation status of CREB and AKT, two main downstream effectors of cAMP, by using phospho-specific antibodies. Because our previous results suggest that ATR does not directly activate ERK1/2 [12] , we analyzed the expression of CEBPB, an ERK1/2-dependent transcription factor, as a potential target of ATR action. A time-course experiment showed that FSH caused a characteristic pattern of transient phosphorylation of kinases, with a rapid (0.5 h) rise in phosphorylation of CREB and AKT, followed by a decrease after 4 h of FSH stimulation. Addition of ATR to the FSH-stimulated GC changed the phosphorylation profile, thus allowing for a prolonged activation of AKT and CREB that lasted 4 h after FSH addition ( Fig. 2A) . Moreover, we analyzed the level of CEBPB, which is early and transiently expressed after FSH stimulation. The results showed that addition of ATR enhanced the FSH-driven CEBPB protein expression (Fig. 2B) . Conversely, ATR alone did not provoke any changes in AKT and CREB phosphorylation and CEBPB expression. These results indicate that ATR disturbs signal transduction by prolonging FSH-induced CREB and AKT phosphorylation and elevating the CEBPB level in GC.
Effect of PI3K Inhibitor Wortmannin and MEK Inhibitor U0126 on Progesterone Biosynthetic Pathway in ATR-and FSH-Stimulated GC Because ATR provoked changes in AKT phosphorylation and CEBPB protein level, we further analyzed whether these pathways were involved in the ATR-induced rise in progesterone level and Star and Cyp11a1 mRNA expression in the FSH-stimulated GC. We pretreated GC with pharmacological inhibitors of PI3K (wortmannin) and MEK (U0126), alone or in a combination, and then stimulated GC with FSH alone or FSH with ATR for 48 h. Our results showed that wortmannin and U0126 applied alone abolished the FSH-induced progesterone production (Fig. 3A) as well as expression of Star (Fig.  3B) and Cyp11a1 (Fig. 3C) . These results confirm that AKTand ERK1/2-signaling cascades are positive regulators of progesterone biosynthesis in the FSH-stimulated GC. More importantly, abolishing AKT and ERK1/2 signaling completely prevented the ATR-induced overproduction of progesterone (Fig. 3A) and overelevation of Star (Fig. 3B) and Cyp11a1 (Fig. 3C) mRNA levels during the FSH stimulation of GC. These results indicate that AKT and ERK1/2 signaling are Cyclic AMP Signaling Is Necessary for ATR Effect on AKT and CEBPB in FSH-Stimulated GC It has been documented that AKT and ERK1/2 can be activated through the cAMP and EGFR pathways after FSH stimulation [18, 19] . In an effort to pinpoint the signaling mechanism by which ATR affects AKT and CEBPB, we used forskolin, an AC and cAMP activator, and EGF, an EGFRsignaling network activator. In the forskolin-stimulated GC, ATR led to overproduction of progesterone (Fig. 4A) and overexpression of Star and Cyp11a1 mRNAs (Fig. 4B) . Moreover, after 4 h of forskolin treatment, we observed an overactivation of AKT and an increase in CEBPB level (Fig.  4C) . On the other hand, ATR failed to produce a similar response in the EGF-stimulated GC (Fig. 4, D and E) . These data indicate that the cAMP-signaling pathway is necessary for ATR action on the progesterone pathway in GC.
Atrazine Affects cAMP-Signaling Pathway by Inhibiting PDE4
Because ATR stimulates cAMP production through inhibition of PDE4 in rat pituitary and testicular Leydig cells [23] , we further hypothesized that PDE4 could be the target of ATR action in the FSH-stimulated GC. To test this, isolated GC were pretreated with a general, nonselective pharmacological inhibitor of PDEs, that is, IBMX and also with a PDE4-specific inhibitor, rolipram. After pretreatment with these inhibitors, the cells were treated with FSH or ATR for 48 h. IBMX and rolipram concentrations were chosen based on the literature data [25] and our previous work [23] . Because Star and Cyp11a1 mRNAs showed the same transcriptional pattern after ATR exposure, in the following experiments, we analyzed only Star mRNA as a marker of GC luteinization. Star mRNA level was assessed by qRT-PCR after 48 h of treatment. IBMX, used in a concentration that inhibits the majority of PDEs, enhanced AKT activation and CEBPB protein level (Fig. 5A ). This was accompanied by a strong overexpression of Star mRNA in the FSH-stimulated GC (Fig. 5B) . To further identify the ATR-specific PDE, we added the PDE4-specific inhibitor rolipram to the FSH-stimulated GC. As expected, when PDE4 activity was blocked, the activity of AKT and level of CEBPB protein and Star mRNA were enhanced in the FSH-stimulated GC. However, addition of ATR to GC in the presence of rolipram failed to further elevate phosphorylation of AKT, CEBPB protein level (Fig. 5C) , and Star mRNA expression (Fig. 5D ) when compared to the FSH-and rolipram-treated GC. These results indicate that PDEs, especially PDE4, could be the target of ATR action in GC.
Atrazine Changes Progesterone:Estradiol Ratio Without Affecting Proliferation in FSH-Stimulated GC
Taking into account our previous results where we demonstrated that ATR decreases the FSH-stimulated aromatase expression and consequently diminishes estradiol production [12] , herein we measured the ratio of progesterone to estradiol in the FSH-and ATR-exposed GC. In the FSHstimulated GC, the production of progesterone was consistently lower than the production of estradiol, bringing the ratio below 1. However, exposure of GC to ATR caused a shift in the ratio of progesterone to estradiol, reaching the value above 1 (Fig.  6A ). This finding is important because a ratio of progesterone FIG. 1. ATR enhances progesterone production as well as Star and Cyp11a1 mRNA expression but has no effect on Esr2 and Pgr transcripts in FSHstimulated rat GC. Immature rat GC were cultured as described in Materials and Methods. Cells were stimulated with 100 ng/ml FSH, 100 ng/ml FSH þ 20 lM ATR, or 20 lM ATR for 48 h. A) Progesterone production in the culture media was measured using ELISA. Quantitative RT-PCR was used to determine the steady-state levels of Star (B), Cyp11a1 (C), Esr2 (D), and Pgr (E) mRNA. Quantitative RT-PCR data were expressed relative to the FSH-induced response in GC without ATR exposure. Each bar represents the mean 6 SEM of five independent experiments. Different superscript letters indicate statistically significant differences among treatment groups (P , 0.05).
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to estradiol above 1 in developing GC is accepted as a clinical marker of the premature luteinization phenotype [34] . Moreover, we also analyzed the potency of ATR to affect the FSHinduced proliferation of GC. Our previous results demonstrated that ATR did not change the cell number in the FSH-stimulated GC after 48 h of treatment [12] . Here, we expanded this experiment by analyzing the expression of selected markers of proliferation such as cyclin D2 (Ccnd2) and cyclin-dependent kinase inhibitor 1B (Cdkn1b) and we also assessed the cell number after 72 h of FSH and ATR treatment. The results of a time-course study showed that ATR caused a small and transient decrease in the FSH-stimulated Ccnd2 mRNA expression after 2 h that quickly returned to the normal level after 6 and 48 h of treatment (Fig. 6B) . Addition of ATR did not change the cell number, as analyzed by the SRB assay (Fig.  6C) , or the expression of Cdkn1b (data not shown). Overall, the results suggest that ATR affects differentiation without interfering with proliferation in the FSH-stimulated GC.
DISCUSSION
Our study showed that at the end of the 48-h stimulation with FSH, ATR exposure induces the following changes in GC: (1) a higher level of progesterone, (2) overexpression of luteal markers (Star and Cyp11a1), and (3) increase in the progesterone:estradiol ratio above 1. We also found that the premature luteinization phenotype in GC occurs through simultaneous stimulation of the cAMP-, AKT-, and CEBPBsignaling pathways. The ability of ATR to raise progesterone level, which is a critical step in early luteinization, has already been demonstrated in preovulatory GC and H295R adrenal cortical carcinoma cells [7] . Moreover, Gojmerac and cowork- 
FIG. 3. MEK and PI3K inhibitors prevent ATR-induced progesterone production as well as
Star and Cyp11a1 mRNA expression in FSHstimulated rat GC. Immature rat GC were cultured as described in Materials and Methods. Cells were pretreated with 10 lM U0126, 0.5 lM wortmannin (Wort), or with a combination of inhibitors for 30 min and then treated with 100 ng/ml FSH in the presence or absence of 20 lM ATR for 48 h. A) Progesterone level was determined by ELISA. Quantitative RT-PCR was used to determine the steady-state levels of Star (B) and Cyp11a1 (C) mRNA, and the qRT-PCR data were expressed relative to the FSHinduced response in GC without ATR exposure. Each bar represents the mean 6 SEM of four to five independent experiments. The results were statistically analyzed in functionally divided sections, ÀATR (left panel) or þATR (right panel). Different superscript letters indicate statistically significant differences among treatment groups (P , 0.05).
PREMATURE LUTEINIZATION IN ATRAZINE-EXPOSED GC
ers [35] found that in vivo exposure of adult pigs to ATR not only increases serum progesterone, but also decreases estradiol level before the onset of estrus. A finding that ATR elevates progesterone level during transition from the immature to the preovulatory stage implies the potential of this pesticide to detrimentally affect ovarian functions, including ovulation events. It has been shown that higher progesterone level inhibits follicle development and potentiates atresia in large preantral follicles [36] . Furthermore, mice with genetic ablation of SMAD4 display higher progesterone level, which is accompanied with severe defects in the cumulus cells and reduced fertility in animals [37] . In addition, a premature progesterone rise in stimulated in vitro fertilization cycles is a frequent phenomenon and is associated with lower pregnancy and implantation rates [38] .
An inappropriate, high expression of Star and Cyp11a1 during FSH stimulation is the key event in the ability of GC to undergo premature luteinization. Star and Cyp11a1 are known luteal markers highly expressed in corpus luteum [39] . StAR protein is responsible for mediating the rate-limiting step in steroidogenesis, transport of cholesterol from the outer to the inner mitochondrial membrane, whereas CYP11A1 catalyzes the initial step of progesterone biosynthesis [40] . Under FSH stimulation, Star and Cyp11a1 expressions are kept at a relatively low level, thus preventing significant progesterone production until GC reached the preovulatory stage and before the luteinizing hormone surge. Cyclic AMP/CREB, AKT, and ERK1/2 are critical positive regulators of progesterone production [19, 41, 42] , whereas factors from the oocyte such as the bone morphogenetic protein family repress it [43] . This creates a specific signaling balance, which prevents excess in progesterone production during early differentiation of GC. Here, we show that ATR affects positive regulators of progesterone biosynthesis by enhancing AKT and CREB phosphorylation and CEBPB protein level in the FSHstimulated GC. Furthermore, pharmacological inhibitors of PI3K and MEK effectively prevented the ATR-induced progesterone biosynthesis, pointing to the significance of downstream kinases in the occurrence of premature activation of the progesterone biosynthetic pathway in GC. It appears that these signaling changes occur through the cAMP/PKAdependent pathway. AKT and CREB are prominent downstream targets of the cAMP/PKA pathway in GC [18] and enhanced phosphorylation of these kinases by ATR suggests activation of cAMP/PKA. Because ATR does not affect ERK1/ 2 phosphorylation [12] , it is reasonable to suggest that the ATR-induced increase in CEBPB occurs through the cAMP pathway as well. It has been shown that CEBPB promoter region has two incomplete CREB-binding sites that contribute to the basal and the PKA-mediated transcriptional control of the gene [44] . Moreover, induction of the Cebpb transcription by 2,3,7,8-tetrachlorodibenzo-p-dioxin is associated with elevated levels of cAMP and is mediated via the PKAdependent pathway in the mouse embryo cells [45] . During selective activation of the cAMP branch by forskolin in our study, ATR was able to enhance CEBPB level and AKT phosphorylation in GC together with an increase in progesterone production and Star and Cyp11a1 mRNA expression. Such an effect by ATR was absent in GC when the EGFR-signaling network was activated by EGF. When the activity of all PDEs   FIG. 4 . ATR enhances progesterone biosynthetic pathway and signaling activity in forskolin-stimulated GC but not in EGF-stimulated rat GC. Immature rat GC were cultured as described in Materials and Methods. Cells were incubated with 1 lM forskolin or 100 ng/ml EGF in the presence or absence of 20 lM ATR. Progesterone level (A) in the culture media and Star and Cyp11a1 mRNA (B, D) were measured after 48 h of treatment. C, E) AKT phosphorylation and CEBPB level were analyzed after 4 h of treatment by Western blots. Quantitative RT-PCR data were expressed relative to the control cells. Representative blots are shown. Each bar represents the mean 6 SEM of three to four independent experiments. Different superscript letters indicate statistically significant differences among treatment groups (P , 0.05).
POGRMIC-MAJKIC ET AL. and more specifically PDE4 was blocked, GC exerted a similar phenotype that resembled the one of ATR. In addition, ATR was not able to exert its effect on Star and AKT or CEBPB signaling when the activity of PDE4 was blocked. All these data point out that ATR changes the properties of cAMP signaling, most likely through PDE4 inhibition, thus initiating a starting point for a further increase in activation of AKT and CEBPB signaling and luteinization phenotype in GC. The ability of ATR to act as a competitive inhibitor of PDE has already been demonstrated [22] . It has also been proposed that ATR stimulates prolactin and testosterone production through inhibition of a specific PDE4 in rat pituitary and testicular Leydig cells [14, 23] . Importantly, follicles in mice with genetic ablation of PDE4D exhibit a premature luteinization phenotype and display entrapped oocytes in the luteinized follicles [25, 27] . It is clear that ATR enhances activation of the positive regulators of progesterone biosynthetic pathway (cAMP, AKT, and ERK1/2), thus amplifying the FSH input on Star and Cyp11a1 and leading to the luteinization phenotype. In our study, GC were physically separated from the oocyte and therefore devoid from a suppressive effect of the oocyte factors. It would be of interest to analyze the effect of ATR on luteinization process in the presence of all the regulatory elements in vivo or in the model of isolated follicles.
Another important FSH function in developing GC is the production of estradiol and expression of Cyp19a1, Lhr, and Ccnd2, all of which are up-regulated during FSH stimulation and represent markers of proliferation and differentiation in GC. Our previous study has shown that ATR decreases estradiol production and Cyp19a1 and Lhr expression in the FSH-stimulated GC under the same experimental conditions as in this study [12] . Estradiol synthesis as well as Cyp19a1 and Lhr expression are controlled by the same signaling mechanisms that influence Star and Cyp11a1 expression [20, 46] . Our results suggest that the interplay between these signaling pathways determines the final output. In the ATR-exposed GC, the cAMP-, AKT-, and ERK1/2-signaling pathways act synergistically on progesterone production and Star and Cyp11a1 expression; however, they have an opposing effect on estradiol, Cyp19a1, and Lhr. The final result is an increase in progesterone with a concomitant decrease in estradiol production. This creates a misbalance in the ratio of progesterone to estradiol in the ATR-exposed GC, reaching a value above 1. It has been documented that the steroid disruption potency of endocrine disruptors is often enabled by a specific interplay between the signaling pathway induced by chemicals and the physiological hormones, as seen in the case of the interaction between 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane [47] or bisphenol A [48] with FSH.
On the other hand, ATR exposure did not affect the proliferative potency of GC as judged by Ccnd2 and Cdkn1b expression and the cell number. It appears that the ATRexposed GC maintain a proliferative expression profile, whereas a number of differentiation markers are overexpressed, FIG. 6. Atrazine increases progesterone to estradiol ratio but does not affect proliferation in FSH-stimulated GC. Immature rat GC were cultured as described in Materials and Methods. Cells were incubated with 100 ng/ml FSH in the presence or absence of 20 lM ATR. A) Ratio of progesterone (P 4 ) to estradiol (E 2 ) in the culture media was measured after 48 h of treatment. B) Quantitative RT-PCR was used to determine the steady-state level of Ccnd2 mRNA at different time points. C) SRB assay was used to determine the cell number after 72 h of treatment. Quantitative RT-PCR data are expressed relative to the FSH-induced response in GC without ATR exposure. Each bar represents the mean 6 SEM of three to five independent experiments. B, C) Different superscript letters indicate statistically significant differences among treatment groups (P , 0.05).
including progesterone, Cyp11a1, and Star, or down-regulated such as estradiol, Cyp19a1, and Lhr. Hence, the growth arrest and differentiation are uncoupled in the ATR-exposed GC, indicating a site-specific action of ATR. The uncoupling of proliferation and differentiation is also seen in CDKN1B-deficient mice, where luteal cells continue to proliferate after hormonal stimulation but arrest does not occur until several days later [49] .
We acknowledge that there are certain limitations to this study. Atrazine has been detected in human follicular fluid at a very low, residual concentration [50] . In the paper by Quignot and collaborators [51] , the authors detected 0.5 lM ATR in rat ovary following an oral administration of 200 mg/kg, leading to disturbance in steroid balance. Because the authors did not measure ATR metabolites, it remains unknown whether ATR was metabolized in the ovary or whether the ovarian effects of ATR came from the parent compound or its metabolites. Moreover, inhibition of both the LH surge and the pulsatile LH release in rats was observed after exposure to 50-300 mg/kg of ATR [52] . Of note, human occupational or dietary exposure is in the range of ,1 to 6 lg/kg/daily [53] . Therefore, the dose of 20 lM (4.3 mg/L) used in this study is above the level routinely found in the environment or the level that humans might be exposed to. However, this particular dose of ATR was used because our experimental approach was such to investigate a rapid, acute effect of this pesticide on GC function and its possible mechanism(s) of action. Moreover, it has been shown that this particular dose and even higher doses of ATR had detrimental effect on reproductive cells [12, 23] . Furthermore, we used an in vitro system, which bears certain limitations, but on the other hand, it can provide valuable information and important guidelines for in vivo studies on animal models.
In conclusion, the results from our study show that ATR disrupts GC function on different levels by modulating the signaling pathways (cAMP and AKT) and the nuclear transcriptional factor (CEBPB), and emphasize PDE4 as a likely starting point of ATR action (Fig. 7) . Overactivation of these signaling cascades causes enhancement of the FSHinduced transcriptional activity, resulting in an inappropriate stimulation of progesterone production, which is a so-called perfect storm that leads to the premature luteinization phenotype in GC. The results from our study provide a few important points for consideration. Our data indicate that ATR can act as a hormone sensitizer. Exposure to ATR increases GC sensitivity to FSH and enhances ligand activation of cAMP-, AKT-, and ERK1/2-signaling and transcriptional activity. These findings suggest that there is a relatively narrow window when GC are more vulnerable to ATR exposure. Women who are exposed to this pesticide are more likely to experience side effects of the FSH action during regular menstrual cycling or in vitro fertilization. The concept of endocrine disruptors as hormone sensitizers has been recognized [54] and represents a new mode of action different from the hormone mimetics. This information could affect the endocrine disruptor-screening program that is focused on hormone mimetic compounds and regulatory systems in order to better protect the reproductive health of women from ATR exposure.
FIG. 7.
Proposed model of ATR action on signaling pathways in FSHstimulated GC. FSH binding to its receptor on the surface of GC is known to activate AC, thus leading to the production of cAMP and activation of PKA. PKA, in turn, phosphorylates CREB and AKT and most likely increases expression of the CEBPB transcriptional factor. In parallel, FSH transactivates the EGFR leading to phosphorylation of ERK1/2, which further increases the activity of CEBPB. Activation of these pathways by FSH initiates progesterone biosynthesis in immature GC. By blocking the activity of PDE4, ATR most likely prevents cAMP degradation. High level of cAMP further enhances the FSH-and PKA-dependent activation of CREB and AKT and the level of CEBPB. Subsequent activation of CEBPB occurs through ERK1/2. Hence, ATR enhances activation of at least three different downstream signaling molecules (CREB, AKT, and ERK1/2) and affects progesterone production during GC proliferation and differentiation. Red arrows indicate pathways affected by ATR; red dashed arrows indicate possible targets of ATR action. TFs, transcriptional factors; PROG, progesterone.
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